Molin, Sonja http://orcid.org/0000-0002-9383-034X
Larsen, Lotte Seiding http://orcid.org/0009-0009-9374-2196
Joensson, Peter http://orcid.org/0009-0004-9609-9072
Oesterdal, Marie Louise
Arbuckle, Rob http://orcid.org/0000-0003-0345-2523
Grant, Laura http://orcid.org/0000-0002-4291-931X
Skingley, George http://orcid.org/0000-0002-7115-0394
Schuttelaar, Marie L. A. http://orcid.org/0000-0002-0766-4382
Clinical trials referenced in this document:
Documents that mention this clinical trial
Development and Psychometric Validation of a Patient-Reported Outcome Measure to Assess the Signs and Symptoms of Chronic Hand Eczema: The Hand Eczema Symptom Diary (HESD)
https://doi.org/10.1007/s13555-024-01114-2
Documents that mention this clinical trial
Development and Psychometric Validation of a Patient-Reported Outcome Measure to Assess the Signs and Symptoms of Chronic Hand Eczema: The Hand Eczema Symptom Diary (HESD)
https://doi.org/10.1007/s13555-024-01114-2
Article History
Received: 21 December 2023
Accepted: 9 February 2024
First Online: 15 March 2024
Declarations
:
: Sonja Molin has received honoraria as consultant/advisor or speaker and/or grants from Abbvie, Almirall, Aralez, Arcutis, Basilea, Bausch and Lomb, Boehringer-Ingelheim, Bristol Myer Squibb, Evidera, Galderma, GSK, Incyte, LEO Pharma A/S, Lilly, Novartis, Pfizer, Sanofi, Sun Pharma and UCB. She is currently investigator for Novartis and LEO Pharma A/S. Lotte Seiding Larsen was an employee of LEO Pharma A/S at the time the work was conducted and now is an employee of H. Lundbeck A/S, Valby, Denmark. Peter Joensson and Marie Louise Oesterdal are employees of LEO Pharma A/S, Ballerup, Denmark. Rob Arbuckle, Laura Grant and George Skingley are employees of Adelphi Values, a health outcomes agency contracted by LEO Pharma A/S to conduct the research. Marie Lousie Schuttelaar has been a consultant, advisory board member, investigator, and/or speaker for Sanofi, Genzyme, Regeneron Pharmaceuticals, Inc., Pfizer, LEO Pharma A/S, Eli Lilly, Galderma, AbbVie, Novartis, and Amgen. SM, SLS and MLS received no honoraria related to the development of this publication.
: All participants provided informed consent indicating their data will be used for medical research purposes and the study results may be published. The studies were performed in accordance with the Helsinki Declaration of 1964 and its later amendments. Ethical approval and oversight for the qualitative interviews was obtained from Group Copernicus Group Independent Review Board (CGIRB; reference ADE1-17-162). Ethical approval for the psychometric validation activities was obtained as part of the phase 2b (NCT03683719) and phase 3 (NCT04871711) trials from the independent institutional review board (IRB) and ethics committees listed in Table InternalRef removed and Table InternalRef removed, respectively.